M. Unkila et al., ALTERATIONS IN PLASMA TRYPTOPHAN BINDING TO ALBUMIN IN 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN-TREATED LONG-EVANS RATS, European journal of pharmacology. Environmental toxicology and pharmacology section, 293(2), 1995, pp. 115-121
We have previously shown that the wasting syndrome in response to 2,3,
7,8-tetrachlorodibenzo-p-dioxin (TCDD) administration is associated wi
th a specific increase in free tryptophan (unbound to albumin) in rats
. The present series of experiments was undertaken to characterize how
the binding of tryptophan to albumin is altered by TCDD and to find t
he underlying cause of the changes. TCDD administered to Long-Evans ra
ts proved to diminish the maximal binding capacity (B-max) of albumin
for tryptophan by ca. 60% without any marked change in the binding aff
inity. Of candidate mediating factors, neither TCDD nor bilirubin affe
cted the binding equilibrium of tryptophan with albumin in vitro. Howe
ver, a mixture of free fatty acids greatly increased the proportion of
free tryptophan at physiologically relevant concentrations. Similarly
, the free fatty acid mixture added to plasma in vitro decreased only
B-max of albumin in a manner similar to the effect of TCDD administere
d in vivo. Extraction of lipid-soluble substances from the plasma with
ether was effective in reversing the increase in free tryptophan in t
he plasma of TCDD-treated rats while dialysis of water-soluble substan
ces was not. Ether extraction also resulted in a decrease in free fatt
y acids. We conclude that disturbances in lipid metabolism may be invo
lved in the pathogenesis of TCDD-induced alterations in tryptophan bin
ding to albumin in vivo.